Aprea Therapeutics, Inc. (APRE) [Rocket]

In millions, except per share items	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	10-K	10-K
Revenues	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0
Selling, general and administrative [+]	8.6	2.3	2.5
General and administrative	8.6	2.3	2.5
Research and development	21.0	14.2	13.4
Other operating expenses	-1.2	-1.0	-0.7
EBITDA [+]	-28.4	-15.5	-15.2
EBITDA growth	82.7%	2.2%
Depreciation and amortization	0.0	0.0	0.0
EBIT [+]	-28.4	-15.5	-15.2
EBIT growth	82.7%	2.2%
Interest income, net [+]	0.2	0.0	0.0
Interest expense		0.0	0.0
Interest income	0.2
Other income (expense), net [+]	0.2	0.0	0.0
Gain (loss) on foreign currency transactions	1.3	1.0	0.7
Other	1.5	1.0	0.7
Pre-tax income	-28.1	-15.5	-15.2
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-28.1	-15.5	-15.2

Basic EPS [+]	($4.67)	($13.45)	($13.17)
Growth	-65.2%	2.1%
Diluted EPS [+]	($4.67)	($13.45)	($13.17)
Growth	-65.2%	2.1%

Shares outstanding (basic) [+]	6.0	1.2	1.2
Growth	420.0%	0.1%
Shares outstanding (diluted) [+]	6.0	1.2	1.2
Growth	420.0%	0.1%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.